Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t Get Meds
The US is is abandoning treatable patients, first by not providing reasonably priced insulin, now by ignoring cancer drug shortages.
Read more...The US is is abandoning treatable patients, first by not providing reasonably priced insulin, now by ignoring cancer drug shortages.
Read more...Why some less-bad-than-expected abortion news is not as good as it seems.
Read more...Credit Suisse, or more accurately, buyer UBS, some execs/board members, and KPMG are targets in a monster RICO suit.
Read more...A deep dive into why big money players have become critical to big corruption.
Read more...The student loan program is a government-enabled transfer of wealth. How surprising is that?
Read more...The Fed’s Powell: Core inflation “has not really moved down. It has not reacted much to our rate hikes. We’re going to have to keep at it.”
Read more...Satyajit Das provides a series on the energy transition, starting with the historical role of energy and supply and demand patterns.
Read more...Every bank crisis has its own overarching narrative and streams of sub-narratives that course through the marketplace day to day.
Read more...More pillaging of America, here in hospitals in flyover, where it won’t be noticed much before those practices start moving to the core.
Read more...Solar panels have a roughly 15 year life. Where do they go to die? The answers now are not very good.
Read more...Osteopaths are increasingly stepping into the primary care gap produced by MDs who increasingly go into lucrative specialities.
Read more...Mortgage predation is baaack! And the Wall Street Journal aids and abets it by choosing not to undertand the issues.
Read more...Lessons learned, and not, from a pandemic that isn’t over.
Read more...Inadequate grid capacity all over the globe raises doubts about the viability of green energy plans, at least at scale.
Read more...The war on plastics has put recycling in its crosshairs.
Read more...